Gastropathy due to celecoxib, a cyclooxygenase-2 inhibitor.
作者： Suneel Mohammed , Dorwyn W. Croom
DOI: 10.1056/NEJM199906243402516
关键词:
摘要: To the Editor: Celecoxib (Celebrex), a cyclooxygenase (COX)-2–specific nonsteroidal antiinflammatory drug (NSAID), was recently introduced in U.S. market. COX-2 is induced inflammation, wher...
sci-hub.se 参考文章(3)
Lee S. Simon, Frank L. Lanza, Peter E. Lipsky, Richard C. Hubbard, Sheela Talwalker, Benjamin D. Schwartz, Peter C. Isakson, G. Steven Geis, Preliminary study of the safety and efficacy of SC‐58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo‐controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects Arthritis & Rheumatism. ,vol. 41, pp. 1591- 1602 ,(1998) , 10.1002/1529-0131(199809)41:9<1591::AID-ART9>3.0.CO;2-J
H Mizuno, C Sakamoto, K Matsuda, K Wada, T Uchida, H Noguchi, T Akamatsu, M Kasuga, Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice Gastroenterology. ,vol. 112, pp. 387- 397 ,(1997) , 10.1053/GAST.1997.V112.PM9024292
John L. Wallace, Adrian Bak, Webb McKnight, Samuel Asfaha, Keith A. Sharkey, Wallace K. MacNaughton, Cyclooxygenase 1 Contributes to Inflammatory Responses in Rats and Mice: Implications for Gastrointestinal Toxicity Gastroenterology. ,vol. 115, pp. 101- 109 ,(1998) , 10.1016/S0016-5085(98)70370-1